BioMerieuxAct RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifFinanzen.nethttp://www.finanzen.netbioMérieux - 2011 Business Reviewhttp://www.finanzen.net/nachricht/bioM-rieux-2011-Business-Review-1589879 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmargb {margin-bottom: 10.0px} .bwmarginl2 {margin-left: 60.0px} .bwmarginl4 ...http://www.finanzen.net/nachricht/bioM-rieux-2011-Business-Review-1589879bioMérieux: Additional Information Following the December 7th Press Releasehttp://www.finanzen.net/nachricht/bioM-rieux-Additional-Information-Following-the-December-7th-Press-Release-1520973 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> At the request of the French "Autorit&eacute; des March&eacute;s Financiers”, bioM&eacute;rieux (Paris:BIM), ...http://www.finanzen.net/nachricht/bioM-rieux-Additional-Information-Following-the-December-7th-Press-Release-1520973bioMérieux - Information on 2011 Sales Objectivehttp://www.finanzen.net/nachricht/bioM-rieux-Information-on-2011-Sales-Objective-1509937 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> bioM&eacute;rieux (Paris:BIM), a world leader in the field of <i>in vitro</i> diagnostics, announces that, ...http://www.finanzen.net/nachricht/bioM-rieux-Information-on-2011-Sales-Objective-1509937bioMérieux Initiative to Support European Antibiotic Awareness Dayhttp://www.finanzen.net/nachricht/bioM-rieux-Initiative-to-Support-European-Antibiotic-Awareness-Day-1481352 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwpadl0 {padding-left: 0.0px} .bwtablemarginb {margin-bottom: 10.0px} .bwvertalignt {vertical-align: top} --> </style> <p ...http://www.finanzen.net/nachricht/bioM-rieux-Initiative-to-Support-European-Antibiotic-Awareness-Day-1481352bioMérieux: Business Review for the Nine Months Ended September 30, 2011http://www.finanzen.net/nachricht/bioM-rieux-Business-Review-for-the-Nine-Months-Ended-September-30-2011-1428175 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmargb {margin-bottom: 10.0px} .bwnowrap {white-space: nowrap} .bwpadb1 ...http://www.finanzen.net/nachricht/bioM-rieux-Business-Review-for-the-Nine-Months-Ended-September-30-2011-1428175bioMérieux - First-Half Results at June 30, 2011http://www.finanzen.net/nachricht/bioM-rieux-First-Half-Results-at-June-30-2011-1359938 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmargb {margin-bottom: 10.0px} .bwmarginl1 {margin-left: 30.0px} .bwnowrap ...http://www.finanzen.net/nachricht/bioM-rieux-First-Half-Results-at-June-30-2011-1359938bioMérieux Expands Its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patientshttp://www.finanzen.net/nachricht/bioM-rieux-Expands-Its-Infectious-Disease-Offering-with-Acquisition-of-ARGENE-Specialized-in-Molecular-Diagnostics-for-Immunocompromised-Patients-1219509 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> bioM&eacute;rieux (Paris:BIM), a world leader in the field of <i>in vitro</i> diagnostics, announced that ...http://www.finanzen.net/nachricht/bioM-rieux-Expands-Its-Infectious-Disease-Offering-with-Acquisition-of-ARGENE-Specialized-in-Molecular-Diagnostics-for-Immunocompromised-Patients-1219509bioMérieux - First-Half 2011 Business Reviewhttp://www.finanzen.net/nachricht/bioM-rieux-First-Half-2011-Business-Review-1219504 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmargb {margin-bottom: 10.0px} .bwmarginl1 {margin-left: 30.0px} .bwmarginl2 ...http://www.finanzen.net/nachricht/bioM-rieux-First-Half-2011-Business-Review-1219504bioMérieux: World HAI Forum: Global Call to Action to Fight Antibiotic Resistancehttp://www.finanzen.net/nachricht/bioM-rieux-World-HAI-Forum-Global-Call-to-Action-to-Fight-Antibiotic-Resistance-1192503 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwlistitemmargb {margin-bottom: 10.0px} --> </style> <p class="bwalignl"> Regulatory News: <!-- sh_cad_1 --> bioM&eacute;rieux (Paris:BIM): ...http://www.finanzen.net/nachricht/bioM-rieux-World-HAI-Forum-Global-Call-to-Action-to-Fight-Antibiotic-Resistance-1192503GE Capital, Franchise Finance Provides $18.5 Million to Hampton Inn & Suites’ and Homewood Suites’ Hotel Company, K Partners Hospitality Group, L.P.http://www.finanzen.net/nachricht/GE-Capital-Franchise-Finance-Provides-18-5-Million-to-Hampton-Inn-Suites-and-Homewood-Suites-Hotel-Company-K-Partners-Hospitality-Group-L-P-1181576 GE Capital, Franchise Finance recently completed an $18.5 million term loan to K Partners Hospitality Group, L.P. for the refinancing of a Hampton Inn Suites and a Homewood Suites located in Lancaster, California. ...http://www.finanzen.net/nachricht/GE-Capital-Franchise-Finance-Provides-18-5-Million-to-Hampton-Inn-Suites-and-Homewood-Suites-Hotel-Company-K-Partners-Hospitality-Group-L-P-1181576